Grant: CIHR Fellowship
McMaster University
$135,000.00
Microbial modulation of visceral sensitivity and brain functions in inflammatory bowel diseases
FY 2023-24
Summary
Chronic abdominal pain is the most common complaint of patients who suffer from gastrointestinal diseases, including those with Inflammatory Bowel Disease (IBD). Abdominal pain is triggered by gut inflammation, but often chronic pain develops or persists in the absence of overt bowel inflammation. Moreover, many patients with IBD face mental health problems, including anxiety and depression. The triggers of both chronic pain and mental health conditions in these patients are unknown, and therefore effective treatments are lacking, pressing the need for better solutions.
Our gut harbours a vast number of bacteria and other microbes collectively named the gut microbiota. In healthy conditions, the interactions with these microbes are beneficial. However, in conditions such as IBD, the equilibrium between the microbiota and the host (humans) is broken, with many unknown consequences. Understanding how bacteria can modulate gut and brain functions, including pain sensation, provides an opportunity for the development of new therapies to treat chronic pain and mood disorders.
My research project aims to identify bacteria responsible for triggering chronic pain and mood disorders in patients with IBD. I will use patient samples in combination with animal models and state-of-the-art research facilities to characterize specific bacteria responsible for increasing pain perception and altering behaviour. I will further describe the underlying biological mechanisms, which we hypothesized to be mediated by the bacterial production of bioactive lipids. These findings will provide the rationale for the development of microbiota-based therapies for chronic abdominal pain and mood disorders.
In Canada, there are more than 300,000 patients with IBD, with a significant proportion suffering from chronic abdominal pain and mood disorders. These patients lack effective treatment and will benefit from new therapeutic strategies.
Department
Program
CIHR Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
492700
Name
Vicentini Fernando A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Microbial modulation of visceral sensitivity and brain functions in inflammatory bowel diseases
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Abdominal Pain; Anxiety; Chronic Pain; Depression; Gut-Brain Axis; Inflammatory Bowel Diseases; Lipid Mediators; Lysophosphatidylcholine; Microbiota; Visceral Sensitivity
Abstract
Chronic abdominal pain is the most common complaint of patients who suffer from gastrointestinal diseases, including those with Inflammatory Bowel Disease (IBD). Abdominal pain is triggered by gut inflammation, but often chronic pain develops or persists in the absence of overt bowel inflammation. Moreover, many patients with IBD face mental health problems, including anxiety and depression. The triggers of both chronic pain and mental health conditions in these patients are unknown, and therefore effective treatments are lacking, pressing the need for better solutions.
Our gut harbours a vast number of bacteria and other microbes collectively named the gut microbiota. In healthy conditions, the interactions with these microbes are beneficial. However, in conditions such as IBD, the equilibrium between the microbiota and the host (humans) is broken, with many unknown consequences. Understanding how bacteria can modulate gut and brain functions, including pain sensation, provides an opportunity for the development of new therapies to treat chronic pain and mood disorders.
My research project aims to identify bacteria responsible for triggering chronic pain and mood disorders in patients with IBD. I will use patient samples in combination with animal models and state-of-the-art research facilities to characterize specific bacteria responsible for increasing pain perception and altering behaviour. I will further describe the underlying biological mechanisms, which we hypothesized to be mediated by the bacterial production of bioactive lipids. These findings will provide the rationale for the development of microbiota-based therapies for chronic abdominal pain and mood disorders.
In Canada, there are more than 300,000 patients with IBD, with a significant proportion suffering from chronic abdominal pain and mood disorders. These patients lack effective treatment and will benefit from new therapeutic strategies.
Competitiondate
202310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Vicentini, Fernando A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~